Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-20-311119
Filing Date
2020-12-07
Accepted
2020-12-07 06:21:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 d63189d425.htm 425 32225
2 GRAPHIC g63189sp002.jpg GRAPHIC 2738
  Complete submission text file 0001193125-20-311119.txt   38003
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filed by) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-51531 | Film No.: 201371288
SIC: 2834 Pharmaceutical Preparations